Related Experiment Video
Updated: Sep 26, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
[Insulin secretion and aging. Implications for insulin therapy in the geriatric patient with diabetes mellitus]
Andreas Fritsche1, Michael Stumvoll, Hans-Ulrich Häring
1Abteilung Innere Medizin I, Medizinische Universitätsklinik, Eberhard-Karls-Universität Tübingen. andreas.fritsche@med.uni-tuebingen.de
Abstract:
Diabetes mellitus has become a global epidemic. With diabetes prevalence highest in old age groups and aging populations, it is the prevalence among the elderly, above all, where most dramatic increases can be expected. The present paper summarizes the age-related metabolic abnormalities resulting in diabetes mellitus, specifically the progressive decline in beta-cell function. In addition, insulin therapy in the elderly is described. Among the many different insulins and therapeutic algorithms, advantages and disadvantages pertaining to the elderly will be highlighted. Specifics in frequency, pathophysiology, and avoidance of severe hypoglycemia in the elderly are discussed.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Pharmacodynamics in Geriatric Patients: Effects of Age
